89 papers found
Refreshing results…
Reduction of LDL Cholesterol in Patients with Primary Hypercholesterolemia by SCH 48461: Results of a Multicenter Dose-Ranging Study
Probucol
Randomized Comparison of the Efficacy and Safety of Cerivastatin and Pravastatin in 1030 Hypercholesterolemic Patients
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels
Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients
Middle-aged men at high risk of cardiovascular disease: the west of scotland coronary prevention study
Lipid-Altering Drugs in Development:
Efficacy and safety of Simvastatin 80 mg/day in hypercholesterolemic patients
Clinical Trial Design for Obesity Agents: A Workshop Report
Drug Interactions of Lipid-Altering Drugs:
New lipid lowering drugs and new effects of old drugs:
Inhibiting Cholesterol Absorption with CP-88,818 (β-Tigogenin Cellobioside; Tiqueside): Studies in Normal and Hyperlipidemic Subjects:
The clinical therapeutic implications of the Scandinavian Simvastatin Survival Study
22 Cholesterol lowering efficacy of simvastatin at doses of 80 and 160 mg/d in a new low systemic exposure formulation
The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/Day
Clinical pharmacologic concepts for the rational selection and use of drugs for the management of dyslipidemia
Efficacy and Tolerability of Low-dose Simvastatin and Niacin, Alone and in Combination, in Patients With Combined Hyperlipidemia: A Prospective Trial
Comparison of two scoring systems used to monitor diets in outpatient clinical trials:
Enhanced low density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy
Expanded clinical evaluation of lovastatin (EXCEL) study results: Two-year efficacy and safety follow-up
Missing publications? Read more about our data sources.